Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

985.60p
   
  • Change Today:
      9.00p
  • 52 Week High: 1,301.50
  • 52 Week Low: 896.20
  • Currency: UK Pounds
  • Shares Issued: 874.35m
  • Volume: 5,727,605
  • Market Cap: £8,618m
  • RiskGrade: 173
  • Beta: 0.01

Smith & Nephew names new audit committee lead

By Benjamin Chiou

Date: Wednesday 06 Dec 2023

LONDON (ShareCast) - (Sharecast News) - Smith & Nephew has announced that non-executive director Rick Medlock has decided to step down after three years at the medical technology group.
Medlock, who joined in April 2020 and later became the chair of the audit committee, will not submit himself for re-election at the company's next annual general meeting.

He will be replaced by non-executive director Jez Maiden, who will be appointed chair of the audit committee from March 2024.

"The board would like to thank Rick for his commitment and contribution to the board and the company and to congratulate Jez on his new appointment," Smith & Nephew said in a statement.

Maiden, who currently also serves on the boards of Travis Perkins and Intertek, joined Smith & Nephew in 2023 after retiring as finance director at Croda International. He has previously headed up the audit committees of other life sciences and healthcare groups such as Synthomer and PZ Cussons.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 985.60p
Change Today 9.00p
% Change 0.92 %
52 Week High 1,301.50
52 Week Low 896.20
Volume 5,727,605
Shares Issued 874.35m
Market Cap £8,618m
Beta 0.01
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.7% below the market average74.7% below the market average74.7% below the market average74.7% below the market average74.7% below the market average
81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average
Price Trend
28.69% below the market average28.69% below the market average28.69% below the market average28.69% below the market average28.69% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Income
8.29% above the market average8.29% above the market average8.29% above the market average8.29% above the market average8.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
46.41% below the market average46.41% below the market average46.41% below the market average46.41% below the market average46.41% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

What The Brokers Say

Strong Buy 6
Buy 5
Neutral 6
Sell 0
Strong Sell 1
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Mar-24 05-Oct-23
Paid 22-May-24 01-Nov-23
Amount 23.10¢ 14.40¢

Trades for 02-May-2024

Time Volume / Share Price
16:39 332 @ 985.60p
16:39 625 @ 985.60p
16:39 1,250 @ 985.60p
16:39 2,500 @ 985.60p
16:39 766 @ 985.60p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page